| New Nicorette miniLozenge - Video New Nicorette mini Lozenge Offers Convenient, Pocket-Sized Support to Help Smokers Looking to Quit feedproxy.google.com |
Medical Radiation a Growing Concern It's true that we get too much radiation, but not from sources we fret about—airport scanners, power lines, cell phones, microwaves. It's from too many medical tests. online.wsj.com |
Latisse Faces Patent Challenge The FDA said a company is challenging Allergan's patent protection for the eyelash drug Latisse, looking to make a generic version. online.wsj.com |
Preparing for Inspire Pharmaceutical's 2011 Phase 3 Catalyst Tony Pelz submits:As most everyone in the biotech space is focused on the events coming in September/October, it’s a good idea to scan for companies with longer term, yet largely ignored, future catalysts. One such company with an impending future catalyst is Inspire Pharmaceuticals (ISPH). Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases.(1) Inspire receives revenues through several product offerings targeting bacterial conjunctivitis, allergic conjunctivitis and dry eye. The referenced future catalyst involves their Phase 3 drug candidate Denufosol Tetrasodium, an inhalation solution for cystic fibrosis. According to the Company:Complete Story » seekingalpha.com |
GeneLink Announces HelixLife Private Label Distribution Agreement [PR Newswire] - GeneLink BioSciences, Inc. today announced the launch of HelixLife, , a private label distribution partnership serving the healthcare and wellness industries. us.rd.yahoo.com |